Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Leonard

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Clinical Lymphoma, Myeloma & Leukemia|October 19, 2024
Sociodemographic Factors Influencing Access to Chimeric Antigen T-Cell Receptor Therapy for Patients With Non-Hodgkin LymphomaSomya Khare, Staci Williamson, Brittany O'Barr, et al.
Sexual Health|February 27, 2025
Understanding the role of patient communication protocols in sexually transmissible infections point-of-care testing among Aboriginal and Torres Strait Islander peoples in remote communities: a qualitative studyRobert Monaghan, Louise Causer, James Ward, et al.
Blood Advances|November 28, 2022
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemiaCurtis A Lachowiez, Nicola Long, Jennifer Saultz, et al.
Transplantation and Cellular Therapy|April 26, 2021
Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or RelapseLaura F Newell, Todd Williams, James Liu, et al.
Sexually Transmitted Infections|June 23, 2026
Impact of decentralised, community-led molecular STI point-of-care testing on testing practices in remote First Nations communities in AustraliaAnnie Tangey, Kirsty Smith, Belinda Hengel, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 9, 2021
Cystic fibrosis foundation consensus statements for the care of cystic fibrosis lung transplant recipientsPali Shah, Erin Lowery, Cecilia Chaparro, et al.
Cancer Discovery|February 17, 2021
Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic LymphomaVinod A Pullarkat, Norman J Lacayo, Elias Jabbour, et al.
Blood Cancer Discovery|May 21, 2025
Genetic and Phenotypic correlates of clinical outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN studyCurtis A Lachowiez, Mael Heiblig, Gaspar Aspas Requena, et al.
Blood Neoplasia|April 20, 2026
Results of a phase 1 trial testing ruxolitinib plus venetoclax in patients with relapsed/refractory acute myeloid leukemiaUma Borate, Cristina E Tognon, Yazan F Madanat, et al.
Nature|October 19, 2018
Functional genomic landscape of acute myeloid leukaemiaJeffrey W Tyner, Cristina E Tognon, Daniel Bottomly, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Clinical Lymphoma, Myeloma & Leukemia|October 19, 2024
Sociodemographic Factors Influencing Access to Chimeric Antigen T-Cell Receptor Therapy for Patients With Non-Hodgkin LymphomaSomya Khare, Staci Williamson, Brittany O'Barr, et al.
Sexual Health|February 27, 2025
Understanding the role of patient communication protocols in sexually transmissible infections point-of-care testing among Aboriginal and Torres Strait Islander peoples in remote communities: a qualitative studyRobert Monaghan, Louise Causer, James Ward, et al.
Blood Advances|November 28, 2022
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemiaCurtis A Lachowiez, Nicola Long, Jennifer Saultz, et al.
Transplantation and Cellular Therapy|April 26, 2021
Engrafted Donor-Derived Clonal Hematopoiesis after Allogenic Hematopoietic Cell Transplantation is Associated with Chronic Graft-versus-Host Disease Requiring Immunosuppressive Therapy, but no Adverse Impact on Overall Survival or RelapseLaura F Newell, Todd Williams, James Liu, et al.
Sexually Transmitted Infections|June 23, 2026
Impact of decentralised, community-led molecular STI point-of-care testing on testing practices in remote First Nations communities in AustraliaAnnie Tangey, Kirsty Smith, Belinda Hengel, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 9, 2021
Cystic fibrosis foundation consensus statements for the care of cystic fibrosis lung transplant recipientsPali Shah, Erin Lowery, Cecilia Chaparro, et al.
Cancer Discovery|February 17, 2021
Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic LymphomaVinod A Pullarkat, Norman J Lacayo, Elias Jabbour, et al.
Blood Cancer Discovery|May 21, 2025
Genetic and Phenotypic correlates of clinical outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN studyCurtis A Lachowiez, Mael Heiblig, Gaspar Aspas Requena, et al.
Blood Neoplasia|April 20, 2026
Results of a phase 1 trial testing ruxolitinib plus venetoclax in patients with relapsed/refractory acute myeloid leukemiaUma Borate, Cristina E Tognon, Yazan F Madanat, et al.
Nature|October 19, 2018
Functional genomic landscape of acute myeloid leukaemiaJeffrey W Tyner, Cristina E Tognon, Daniel Bottomly, et al.
Pageof 3